Microba Life Sciences Limited (ASX:MAP)

Microba Life Sciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	7.95	11.74	20.89	32.04	30.58
Short-Term Investments	-	-	0.2	0.2	0.2
Cash & Short-Term Investments	7.95	11.74	21.09	32.25	30.79
Cash Growth	-32.31%	-44.34%	-34.59%	4.75%	136.28%
Accounts Receivable	0.84	0.83	1.64	0.72	0.64
Other Receivables	2.37	3.28	6.47	6.51	2.78
Receivables	3.21	4.11	8.1	7.24	3.42
Inventory	2.22	1.94	2.24	0.64	0.36
Prepaid Expenses	0.52	0.88	0.8	1.4	1.25
Other Current Assets	-	0.19	0.01	-	-
Total Current Assets	13.89	18.86	32.25	41.53	35.82
Property, Plant & Equipment	2.32	3.87	3.91	2.58	2.81
Long-Term Investments	0.26	0.14	-	-	-
Goodwill	9.2	10.02	9.09	-	-
Other Intangible Assets	10.86	12.21	10.39	0.19	0.21
Long-Term Deferred Charges	3.28	2.34	3.04	2.66	0.64
Total Assets	39.81	47.44	58.68	46.95	39.48

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	2.64	2.35	3.7	2.98	0.81
Accrued Expenses	1.88	2.17	1.87	1.72	1.42
Short-Term Debt	2.18	0.32	0.4	0.36	0.36
Current Portion of Long-Term Debt	0.2	0.43	-	-	-
Current Portion of Leases	0.94	0.99	0.81	0.55	0.48
Current Income Taxes Payable	0.03	0.01	0.01	0.01	-
Current Unearned Revenue	2.32	1.99	2.31	1.35	1.06
Other Current Liabilities	1	1.91	3.28	0.87	1.13
Total Current Liabilities	11.19	10.17	12.37	7.82	5.26
Long-Term Debt	0.36	0.47	-	-	-
Long-Term Leases	0.43	1.03	0.37	0.23	0.48
Long-Term Unearned Revenue	1.73	0.98	0.46	0.15	0.1
Pension & Post-Retirement Benefits	0.07	0.12	0.23	0.17	0.1
Long-Term Deferred Tax Liabilities	1.65	2.17	2.21	-	-
Other Long-Term Liabilities	-	-	1.83	-	-
Total Liabilities	15.43	14.94	17.47	8.38	5.94

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	120.46	108.54	102.88	80.37	62.88
Retained Earnings	-99.48	-78.76	-63.82	-43.88	-31.2
Comprehensive Income & Other	3.4	2.71	2.16	2.08	1.85
Shareholders' Equity	24.38	32.49	41.22	38.57	33.54
Total Liabilities & Equity	39.81	47.44	58.68	46.95	39.48

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	4.11	3.23	1.58	1.14	1.33
Net Cash (Debt)	3.84	8.51	19.51	31.11	29.46
Net Cash Growth	-54.85%	-56.40%	-37.28%	5.60%	130.88%
Net Cash Per Share	0.01	0.02	0.05	0.10	0.13
Filing Date Shares Outstanding	700.31	515.03	447.85	344.14	274.36
Total Common Shares Outstanding	700.31	515.03	447.85	344.14	274.36
Working Capital	2.7	8.69	19.88	33.7	30.55
Book Value Per Share	0.03	0.06	0.09	0.11	0.12
Tangible Book Value	4.32	10.27	21.73	38.39	33.33
Tangible Book Value Per Share	0.01	0.02	0.05	0.11	0.12
Machinery	6.52	7.16	6.76	4.83	4.39

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 16, 2026

Data Sources Report a data error